These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3920957)

  • 21. Evaluation of various methods of susceptibility to ofloxacin in strains of Mycobacterium tuberculosis.
    Sulochana S; Venkataraman P; Paramasivan CN
    Indian J Med Res; 1999 Dec; 110():186-9. PubMed ID: 10701297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT; Andriole VT
    Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recovery and susceptibility testing of Mycobacterium tuberculosis from extrapulmonary specimens by the BACTEC radiometric method.
    Fadda G; Roe SL
    J Clin Microbiol; 1984 May; 19(5):720-1. PubMed ID: 6429193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex.
    Bemer-Melchior P; Bryskier A; Drugeon HB
    J Antimicrob Chemother; 2000 Oct; 46(4):571-6. PubMed ID: 11020254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of cefoxitin and parenterally administered cephalosporins against anaerobic bacteria.
    Sutter VL; Kirby B; Finegold SM
    Rev Infect Dis; 1979; 1(1):218-23. PubMed ID: 318226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1983 Aug; 80(2):182-9. PubMed ID: 6881092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis.
    Siddiqi SH; Libonati JP; Middlebrook G
    J Clin Microbiol; 1981 May; 13(5):908-12. PubMed ID: 6787076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH; Opfer BJ; Gerding DN
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antibacterial activity of moxalactam, a new broad-spectrum semisynthetic antibiotic.
    Skalova R; Hajsig D; Muic V; Kapun D
    Infection; 1980; 8 Suppl 3():S 330-3. PubMed ID: 6447672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of minimal inhibitory concentrations of antituberculosis drugs by radiometric and conventional methods.
    Lee CN; Heifets LB
    Am Rev Respir Dis; 1987 Aug; 136(2):349-52. PubMed ID: 3619193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria.
    Jorgensen JH; Crawford SA; Alexander GA
    Antimicrob Agents Chemother; 1980 May; 17(5):901-4. PubMed ID: 6249198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion.
    Tortoli E; Benedetti M; Fontanelli A; Simonetti MT
    J Clin Microbiol; 2002 Feb; 40(2):607-10. PubMed ID: 11825978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.
    Mouton RP; Bongaerts GP; van Gestel M; Bruggeman-Ogle KM
    Chemotherapy; 1981; 27(5):318-24. PubMed ID: 6455258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonweekend schedule for BACTEC drug susceptibility testing of Mycobacterium tuberculosis.
    Hawkins JE
    J Clin Microbiol; 1986 May; 23(5):934-7. PubMed ID: 3086371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
    Goering RV; Sanders CC; Sanders W
    J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative antimicrobial activity of aminothiazolyl methoxyimino cephalosporins against anaerobic bacteria, including 100 cefoxitin-resistant isolates.
    Jones RN; Barry AL; Aldridge KE; Gerlach EH
    Diagn Microbiol Infect Dis; 1987 Nov; 8(3):157-63. PubMed ID: 3501976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamics of resistance to cephalosporins.
    Atkinson BA
    Chemioterapia; 1985 Feb; 4(1):19-23. PubMed ID: 3986942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
    Thabaut A; Durosoir JL; Saliou P
    Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of the in vitro activity of new cephalosporins on strains of Neisseria gonorrhoeae of the Toulouse region.
    Prère MF; Lefèvre JC; Lareng MB
    Chemotherapy; 1981; 27 Suppl 1():15-8. PubMed ID: 6265158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of LY127935.
    Fass RJ
    Antimicrob Agents Chemother; 1979 Oct; 16(4):503-9. PubMed ID: 518080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.